M1-polarized TAMs release reactive oxygen and nitrogen intermediates to kill cancer cells or release immunomodulatory factors, such as interleukin-1β (IL-1β) and IL-12, which provoke CD8+ T cells to attack cancer cells [13,14]. The gene discussed is IL1B; the disease is cancer.